Searching map area
A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mi
? TBD
scientific article published on 27 April 2007
Join to rate
Ratings
0
Nobody has rated this yet. Be the first!
Lists
0
Join to rate
Instance of
Scholarly article
Subject
Multicenter trial
Bladder cancer
Wikidata